Superior Mesenteric Vein Stenting for Management of Complications of Mesenteric Desmoplasia in Midgut Neuroendocrine Tumors Abstract #984

Introduction: Mesenteric fibrosis is a cause of morbidity and mortality in patients with midgut neuroendocrine tumors (mNETs). It may cause occlusion of the superior mesenteric vein (SMV), which can be associated with development ascites and mesenteric and small bowel varices (SBVs) leading to occult gastrointestinal (GI) bleeding.
Aim(s): To investigate the role of SMV stents in management of ascites and SBVs in mNETs patients.
Materials and methods: Five patients (three male, two female) were included. All patients had G1 mNETs, and evidence of inoperable mesenteric disease, desmoplasia and SMV occlusion.
Conference: 11th Annual ENETS Conference (2014)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Dr Keval B Naik

To read results and conclusion, please login ...

Further abstracts you may be interested in

#243 Morbidity and Mortality Associated with Desmoplasia in Midgut Neuroendocrine Tumors (NETs)
Introduction: The clinical course of midgut NETs may be heavily complicated by problems related to mesenteric desmoplasia, causing symptoms secondary to mesenteric artery/vein occlusion and bowel obstruction.
Conference: 8th Annual ENETS Conference (2011)
Category: Basic
Presenting Author: Dr Fatima El-Khouly
#982 Rectal Neuroendocrine Tumors: A Review of Clinical Outcomes
Introduction: Rectal neuroendocrine tumors (rNETs) are increasing in incidence, with more found incidentally on routine colonoscopy.
Conference: 11th Annual ENETS Conference (2014)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Dr Keval B Naik
Keywords: rectal NETs
#526 Association Between Activin A & NT-pro-BNP in Carcinoid Heart Disease and Intestinal Desmoplasia in Patients with Metastatic Midgut and Pelvic NET
Introduction: Carcinoid heart disease (CHD) involves cardiac valvular fibrosis and volume overload. N-terminal pro-brain natriuretic peptide (NT-pro-BNP) is released by the myocardium in response to increased wall stress in CHD. Activin A is a member of the TGF-ß superfamily involved in fibrogenesis.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr Daniel Knight
Authors: Knight D, Khan M, Gobinathan S, Nair D, ...
#1072 Predictive Factors for Antiproliferative Activity of Octreotide LAR in Advanced Neuroendocrine Tumors
Introduction: The antiproliferative activity of Octreotide LAR in Neuroendocrine Tumors(NETs) has been demonstrated by small retrospective studies and confirmed by a prospective phase III trial(PROMID).However,there are limited data about the duration and predictors of response.
Conference: 12th Annual ENETS Conference (2015)
Category: Medical treatment - SMS analogues, interferon
Presenting Author: Faidon Laskaratos
Keywords: octreotide LAR, NETs
#1744 Predictors of Survival in Patients with Small Intestinal Neuroendocrine Tumours (SINETs) Associated with Mesenteric Desmoplasia
Introduction: SINETs represent 30-50% of small bowel neoplasms with a rising incidence and can be associated with mesenteric fibrosis (MF)
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Faidon M Laskaratos
Keywords: SINETs